Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Yan DB et al. - The mean IOP in the first period when all patients were dosed in the evening was assessed 12 h after dosing at 09:00 and it was similar in the two treatment groups. In the a.m.-dosing crossover comparison, the 24-h post-dose IOP was significantly lower on travoprost compared to latanoprost.


Previous Article Next Article

Today in Drug Interactions...keeping you current

Gemcitabine and oxaliplatin combination chemotherapy for metastatic well-differentiated neuroendocrine carcinomas
Cancer, 06/01/09

A population-based clinical trial of irinotecan and carboplatin
Journal of Oncology, 06/15/09

Rifampin and Linezolid in the Treatment of Methicillin-Resistant Staphylococcus aureus Preseptal Cellulitis
Ophthalmic Plastic and Reconstructive Surgery, 06/05/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address